Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic

Emergency authorized coronavirus disease 2019 (COVID-19)–neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons...

Descripción completa

Detalles Bibliográficos
Autores principales: Bariola, J Ryan, McCreary, Erin K, Khadem, Tina, Snyder, Graham M, Wadas, Richard J, Nace, David A, White, Douglas B, Yealy, Donald M, Schmidhofer, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083628/
https://www.ncbi.nlm.nih.gov/pubmed/34322560
http://dx.doi.org/10.1093/ofid/ofab151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083628/
https://www.ncbi.nlm.nih.gov/pubmed/34322560
http://dx.doi.org/10.1093/ofid/ofab151

Ejemplares similares